CD36 genetics and the metabolic complications of obesity

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 14, Issue 6, 2011, Pages 527-534

  Love Gregory, Latisha ^a   Abumrad, Nada A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD36; cholesterol; obesity; polymorphisms; triglyceride

Indexed keywords

CD36 ANTIGEN; LIPID; TRIACYLGLYCEROL;

ADIPOSE TISSUE; CARDIOVASCULAR DISEASE; CD36 GENE; FAT INTAKE; GENE; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFLAMMATION; LIPID METABOLISM; METABOLIC DISORDER; NONHUMAN; OBESITY; PHENOTYPE; REVIEW; RODENT; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TASTE;

ADIPOSE TISSUE; ANTIGENS, CD36; CARDIOVASCULAR DISEASES; DIETARY FATS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPID METABOLISM; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; SIGNAL TRANSDUCTION;

RODENTIA;

EID: 80054973133     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32834bbac9     Document Type: Review

References (76)

1. Brodeur MR, Brissette L, Falstrault L, et al. Scavenger receptor of class B expressed by osteoblastic cells are implicated in the uptake of cholesteryl ester and estradiol from LDL and HDL3. J Bone Miner Res 2008; 23:326-337. (Pubitemid 351304663)
2. Luangrath V, Brodeur MR, Rhainds D, Brissette L. Mouse CD36 has opposite effects on LDL and oxidized LDL metabolism in vivo. Arterioscler Thromb Vasc Biol 2008; 28:1290-1295.
3. Brundert M, Heeren J, Merkel M, et al. Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells. J Lipid Res 2011; 52:745-758.
4. Collot-Teixeira S, Martin J, McDermott-Roe C, et al. CD36 and macrophages in atherosclerosis. Cardiovasc Res 2007; 75:468-477. (Pubitemid 47080960)
5. Heilbronn LK, Gregersen S, Shirkhedkar D, et al. Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes. Diabetes 2007; 56:2046-2053. (Pubitemid 47195816)
6. Kashyap SR, Ioachimescu AG, Gornik HL, et al. Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL. Obesity (Silver Spring) 2009; 17:2142-2148.
7. Park YM, Febbraio M, Silverstein RL. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 2009; 119:136-145.
8. Rahaman SO, Lennon DJ, Febbraio M, et al. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell Metab 2006; 4:211-221. (Pubitemid 44283954)
9. Silverstein RL, Febbraio M. CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior. Sci Signal 2009; 2:re3.
10. Su X, Abumrad NA. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol Metab 2009; 20:72-77.
11. Ikeda H, Mitani T, Ohnuma M, et al. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion. Vox Sang 1989; 57:213-217. (Pubitemid 19249900)
12. Aitman TJ, Cooper LD, Norsworthy PJ, et al. Malaria susceptibility and CD36 mutation. Nature 2000; 405:1015-1016. (Pubitemid 30447776)
13. Yanai H, Chiba H, Morimoto M, et al. Type I CD36 deficiency in humans is not associated with insulin resistance syndrome. Thromb Haemost 2000; 83:786. (Pubitemid 30248531)
14. Yamamoto N, Akamatsu N, Sakuraba H, et al. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 1994; 83:392-397. (Pubitemid 24030564)
15. Furuhashi M, Ura N, Nakata T, et al. Genotype in human CD36 deficiency and diabetes mellitus. Diabet Med 2004; 21:952-953. (Pubitemid 39037016)
16. Kamiya M, Nakagomi A, Tokita Y, et al. Type I CD36 deficiency associated with metabolic syndrome and vasospastic angina: a case report. J Cardiol 2006; 48:41-44.
17. Nagasaka H, Yorifuji T, Takatani T, et al. CD36 deficiency predisposing young children to fasting hypoglycemia. Metabolism 2011; 60:881-887.
18. Yasunaga T, Koga S, Ikeda S, et al. Cluster differentiation-36 deficiency type 1 and acute coronary syndrome without major cardiovascular risk factors: case report. Circ J 2007; 71:166-169. (Pubitemid 46045567)
19. Yoshizumi T, Nozaki S, Fukuchi K, et al. Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects. J Nucl Med 2000; 41:1134-1138. (Pubitemid 30463994)
20. Love-Gregory L, Sherva R, Schappe T, et al. Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profile. Hum Mol Genet 2011; 20:193-201.
21. Handberg A, Levin K, Hojlund K, Beck-Nielsen H. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: a novel marker of insulin resistance. Circulation 2006; 114:1169-1176. (Pubitemid 44386481)
22. Sun Y, Scavini M, Orlando RA, et al. Increased CD36 expression signals monocyte activation among patients with type 2 diabetes mellitus. Diabetes Care 2010; 33:2065-2067.
23. Silverstein RL. Inflammation, atherosclerosis, and arterial thrombosis: role of the scavenger receptor CD36. Cleve Clin J Med 2009; 76 (Suppl 2):S27-S30.
24. Lepretre F, Linton KJ, Lacquemant C, et al. Genetic study of the CD36 gene in a French diabetic population. Diabetes Metab 2004; 30:459-463. (Pubitemid 39648014)
25. Arya R, Blangero J, Williams K, et al. Factors of insulin resistance syndromerelated phenotypes are linked to genetic locations on chromosomes 6 and 7 in nondiabetic Mexican-Americans. Diabetes 2002; 51:841-847. (Pubitemid 34760198)
26. Lehman DM, Arya R, Blangero J, et al. Bivariate linkage analysis of the insulin resistance syndrome phenotypes on chromosome 7q. Hum Biol 2005; 77:231-246. (Pubitemid 41170454)
27. Malhotra A, Elbein SC, Ng MC, et al. Meta-analysis of genome-wide linkage studies of quantitative lipid traits in families ascertained for type 2 diabetes. Diabetes 2007; 56:890-896. (Pubitemid 46348475)
28. Ma X, Bacci S, Mlynarski W, et al. A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet 2004; 13:2197-2205. (Pubitemid 39359920)
29. Laugerette F, Passilly-Degrace P, Patris B, et al. CD36 involvement in orosensory detection of dietary lipids, spontaneous fat preference, and digestive secretions. J Clin Invest 2005; 115:3177-3184. (Pubitemid 41567582)
30. Martin C, Chevrot M, Poirier H, et al. CD36 as a lipid sensor. Physiol Behav [Epub ahead of print]. doi:10.1016/j.physbeh.2011.02.029.
31. Sclafani A, Ackroff K, Abumrad NA. CD36 gene deletion reduces fat preference and intake but not postoral fat conditioning in mice. Am J Physiol Regul Integr Comp Physiol 2007; 293:R1823-R1832. (Pubitemid 350085658)
32. Zhang XJ, Zhou LH, Ban X, et al. Decreased expression of CD36 in circumvallate taste buds of high-fat diet induced obese rats. Acta Histochem 2011; 113:663-667.
33. Stewart JE, Feinle-Bisset C, Golding M, et al. Oral sensitivity to fatty acids, food consumption and BMI in human subjects. Br J Nutr 2010; 104:145-152.
34. Stewart JE, Seimon RV, Otto B, et al. Marked differences in gustatory and gastrointestinal sensitivity to oleic acid between lean and obese men. Am J Clin Nutr 2011; 93:703-711.
35. Simons PJ, Kummer JA, Luiken JJ, Boon L. Apical CD36 immunolocalization in human and porcine taste buds from circumvallate and foliate papillae. Acta Histochem 2010. [Epub ahead of print]. doi:10.1016/j.acthis.2010.08.006
36. Newberry EP, Davidson NO. Intestinal lipid absorption, GLP-2, and CD36: still more mysteries to moving fat. Gastroenterology 2009; 137:775-778.
37. Schwartz GJ. Gut fat sensing in the negative feedback control of energy balance: recent advances. Physiol Behav 2011. [Epub ahead of print]. doi:10.1016/j.physbeh.2011.05.003
38. Iqbal J, Hussain MM. Intestinal lipid absorption. Am J Physiol Endocrinol Metab 2009; 296:E1183-E1194.
39. Tran TT, Poirier H, Clement L, et al. Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis. J Biol Chem 2011; 286:25201-25210.
40. Siddiqi S, Saleem U, Abumrad NA, et al. A novel multiprotein complex is required to generate the prechylomicron transport vesicle from intestinal ER. J Lipid Res 2010; 51:1918-1928.
41. Drover VA, Ajmal M, Nassir F, et al. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. J Clin Invest 2005; 115:1290-1297. (Pubitemid 40629048)
42. Masuda D, Hirano K, Oku H, et al. Chylomicron remnants are increased in the postprandial state in CD36 deficiency. J Lipid Res 2009; 50:999-1011.
43. Hall D, Mayosi BM, Rahman TJ, et al. Common variation in the CD36 (fatty acid translocase) gene is associated with left-ventricular mass. J Hypertens 2011; 29:690-695.
44. Madden J, Carrero JJ, Brunner A, et al. Polymorphisms in the CD36 gene modulate the ability of fish oil supplements to lower fasting plasma triacyl glycerol and raise HDL cholesterol concentrations in healthy middle-aged men. Prostaglandins Leukot Essent Fatty Acids 2008; 78:327-335.
45. Ghosh A, Murugesan G, Chen K, et al. Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms. Blood 2011; 117:6355-6366.
46. Lecompte S, Szabo de Edelenyi F, Goumidi L, et al. Polymorphisms in the CD36/FAT gene are associated with plasma vitamin E concentrations in humans. Am J Clin Nutr 2011; 93:644-651.
47. Borel P, de Edelenyi FS, Vincent-Baudry S, et al. Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans. Ann Med 2011; 43:47-59.
48. Goyenechea E, Collins LJ, Parra D, et al. CD36 gene promoter polymorphisms are associated with low density lipoprotein-cholesterol in normal twins and after a low-calorie diet in obese subjects. Twin Res Hum Genet 2008; 11:621-628.
49. Heni M, Mussig K, Machicao F, et al. Variants in the CD36 gene locus determine whole-body adiposity, but have no independent effect on insulin sensitivity. Obesity (Silver Spring) 2011; 19:1004-1009.
50. Bokor S, Legry V, Meirhaeghe A, et al. Single-nucleotide polymorphism of CD36 locus and obesity in European adolescents. Obesity (Silver Spring) 2010; 18:1398-1403.
51. Kondo N, Honda S, Kuno S, Negi A. Positive association of common variants in CD36 with neovascular age-related macular degeneration. Aging (Albany NY) 2009; 1:266-274.
52. Love-Gregory L, Sherva R, Sun L, et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet 2008; 17:1695-1704. (Pubitemid 351737173)
53. Arnett DK, Li N, Tang W, et al. Genome-wide association study identifies single-nucleotide polymorphism in KCNB1 associated with left ventricular mass in humans: the HyperGEN Study. BMC Med Genet 2009; 10:43.
54. Corpeleijn E, van der Kallen CJ, Kruijshoop M, et al. Direct association of a promoter polymorphism in the CD36/FAT fatty acid transporter gene with type 2 diabetes mellitus and insulin resistance. Diabet Med 2006; 23:907-911. (Pubitemid 44141081)
55. Taguchi K, Yamagata HD, Zhong W, et al. Identification of hippocampusrelated candidate genes for Alzheimer's disease. Ann Neurol 2005; 57:585-588. (Pubitemid 40471174)
56. Ikram MA, Seshadri S, Bis JC, et al. Genomewide association studies of stroke. N Engl J Med 2009; 360:1718-1728.
57. Knowles JW, Wang H, Itakura H, et al. Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction. Am Heart J 2007; 154:1052-1058. (Pubitemid 350116028)
58. Morii T, Ohno Y, Kato N, et al. CD36 single nucleotide polymorphism is associated with variation in low-density lipoprotein-cholesterol in young Japanese men. Biomarkers 2009; 14:207-212.
59. Noel SE, Lai CQ, Mattei J, et al. Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults. Atherosclerosis 2010; 211:210-215.
60. Hsieh J, Longuet C, Maida A, et al. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology 2009; 137:997-1005; 1005 e1-1005 e4.
61. Schwartz GJ, Fu J, Astarita G, et al. The lipid messenger OEA links dietary fat intake to satiety. Cell Metab 2008; 8:281-288.
62. Thabuis C, Destaillats F, Lambert DM, et al. Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice. J Lipid Res 2011; 52:1373-1382.
63. McQuaid SE, Hodson L, Neville MJ, et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes 2011; 60:47-55.
64. Mittendorfer B, Magkos F, Fabbrini E, et al. Relationship between body fat mass and free fatty acid kinetics in men and women. Obesity (Silver Spring) 2009; 17:1872-2187.
65. Cusi K. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep 2010; 10:306-315.
66. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23:201-229. (Pubitemid 34299024)
67. Goldberg IJ, Eckel RH, Abumrad NA. Regulation of fatty acid uptake into tissues: lipoprotein lipase-and CD36-mediated pathways. J Lipid Res 2009; 50. (Suppl.):S86-S90.
68. Koutsari C, Ali AH, Mundi MS, Jensen MD. Storage of circulating free fatty acid in adipose tissue of postabsorptive humans: quantitative measures and implications for body fat distribution. Diabetes 2011. [Epub ahead of print]. doi:10.1016/j.physbeh.2011.05.003
69. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006; 26:968-976. (Pubitemid 43732100)
70. Bays HE. Adiposopathy is 'sick fat' a cardiovascular disease? J Am Coll Cardiol 2011; 57:2461-2473.
71. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010; 72:219-246.
72. Kennedy DJ, Kuchibhotla S, Westfall KM, et al. A CD36-dependent pathway enhances macrophage and adipose tissue inflammation and impairs insulin signalling. Cardiovasc Res 2011; 89:604-613.
73. Vallerie SN, Hotamisligil GS. The role of JNK proteins in metabolism. Sci Transl Med 2010; 2:60rv5.
74. Choquet H, Labrune Y, De Graeve F, et al. Lack of association of CD36 SNPs with early onset obesity: a meta-analysis in 9,973 European subjects. Obesity (Silver Spring) 2011; 19:833-839.
75. Yun YM, Song EY, Song SH, et al. CD36 polymorphism and its relationship with body mass index and coronary artery disease in a Korean population. Clin Chem Lab Med 2007; 45:1277-1282.
76. Kuda O, Jenkins CM, Skinner JR, et al. CD36 protein is involved in storeoperated calcium flux, phospholipase A2 activation, and production of prostaglandin E2. J Biol Chem 2011; 286:17785-17795.